Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Pharm Res. 2012 Oct;35(10):1701-11. doi: 10.1007/s12272-012-1001-2. Epub 2012 Nov 9.

Roles of phosphoinositides and phosphoinositides kinases in hepatitis C virus RNA replication.

Author information

1
Dongguk University College of Pharmacy, Goyang, Korea. choongholee@dongguk.edu

Abstract

Phosphoinositides (PIs) play an essential role in mediating key signaling pathways on biological membranes. Hepatitis C virus (HCV) replicates its RNA genome by establishing a viral replication complex (RC) on host cell membranes. Recently, an increasing body of literature reported that not only PIs themselves but also several PIs-specific kinases are required for efficient replication of HCV RNA genome. Especially, PI 4-kinases type III alpha, beta as well as their enzymatic products including phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) are consistently identified to be host factors essential for HCV replication. In this article, the current state of our knowledge of PIs and PIs-specific kinases together with their roles in modulating HCV replication is reviewed. The effects of various PIs-specific kinases inhibitors on HCV replication are also highlighted, proposing them as promising candidate targets to which a new class of anti-HCV therapeutics can be envisaged.

PMID:
23139120
DOI:
10.1007/s12272-012-1001-2
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center